首例由 COVID-19 感染并发的费尔蒂综合征病例

IF 4.2 2区医学 Q2 IMMUNOLOGY Journal of Inflammation Research Pub Date : 2024-11-14 eCollection Date: 2024-01-01 DOI:10.2147/JIR.S479377

Yueming Li, Fanyou Zhu, Rui Wen, Tingting Hou, Rou Xie, Jiao Qin

{"title":"首例由 COVID-19 感染并发的费尔蒂综合征病例","authors":"Yueming Li, Fanyou Zhu, Rui Wen, Tingting Hou, Rou Xie, Jiao Qin","doi":"10.2147/JIR.S479377","DOIUrl":null,"url":null,"abstract":"Felty's syndrome (FS) is an uncommon disorder with a poor prognosis, and most patients die from infections caused by neutropenia. Currently, there is no standardized treatment strategy, and treatment options are based on case reports and clinical experience. To date, no cases of FS complicated by coronavirus disease-2019 (COVID-19) have been reported. This article reports a successful case of FS complicated by COVID-19. We emphasized treating rheumatic diseases with immunosuppressive therapy at appropriate doses based on strong and effective anti-infection when co-infected.","PeriodicalId":16107,"journal":{"name":"Journal of Inflammation Research","volume":"17 ","pages":"8853-8860"},"PeriodicalIF":4.2000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571983/pdf/","citationCount":"0","resultStr":"{\"title\":\"The First Case of Felty's Syndrome Complicated by COVID-19 Infection.\",\"authors\":\"Yueming Li, Fanyou Zhu, Rui Wen, Tingting Hou, Rou Xie, Jiao Qin\",\"doi\":\"10.2147/JIR.S479377\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Felty's syndrome (FS) is an uncommon disorder with a poor prognosis, and most patients die from infections caused by neutropenia. Currently, there is no standardized treatment strategy, and treatment options are based on case reports and clinical experience. To date, no cases of FS complicated by coronavirus disease-2019 (COVID-19) have been reported. This article reports a successful case of FS complicated by COVID-19. We emphasized treating rheumatic diseases with immunosuppressive therapy at appropriate doses based on strong and effective anti-infection when co-infected.\",\"PeriodicalId\":16107,\"journal\":{\"name\":\"Journal of Inflammation Research\",\"volume\":\"17 \",\"pages\":\"8853-8860\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2024-11-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571983/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Inflammation Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/JIR.S479377\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Inflammation Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/JIR.S479377","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

费尔蒂综合征（Felty's Syndrome，FS）是一种不常见的疾病，预后较差，大多数患者死于中性粒细胞减少引起的感染。目前，还没有标准化的治疗策略，治疗方案主要基于病例报告和临床经验。迄今为止，尚无冠状病毒病-2019（COVID-19）并发 FS 的病例报道。本文报告了一例成功的冠状病毒病-2019（COVID-19）并发 FS 的病例。我们强调在合并感染时，在强效抗感染的基础上以适当剂量的免疫抑制剂治疗风湿性疾病。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

The First Case of Felty's Syndrome Complicated by COVID-19 Infection.

Felty's syndrome (FS) is an uncommon disorder with a poor prognosis, and most patients die from infections caused by neutropenia. Currently, there is no standardized treatment strategy, and treatment options are based on case reports and clinical experience. To date, no cases of FS complicated by coronavirus disease-2019 (COVID-19) have been reported. This article reports a successful case of FS complicated by COVID-19. We emphasized treating rheumatic diseases with immunosuppressive therapy at appropriate doses based on strong and effective anti-infection when co-infected.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Inflammation Research Immunology and Microbiology-Immunology

CiteScore

6.10

自引率

2.20%

发文量

658

审稿时长

16 weeks

期刊介绍： An international, peer-reviewed, open access, online journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation.